Clinical Trial Update: Antiplatelet Effects of Tirofiban vs. Cangrelor N-STEMI Patients Undergoing Percutaneous Coronary Intervention

View source ↗

Summary

Trial comparing antiplatelet effects of tirofiban versus cangrelor in NSTEMI patients undergoing PCI; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-st-elevation Myocardial Infarction

Drugs mentioned

• Cangrelor (cangrelor)
• tirofiban (tirofiban)

Snippet

Sponsor: Inova Health Care Services | Conditions: Non-ST Elevation Myocardial Infarction (NSTEMI) | Status: TERMINATED | Results posted: 2023-12-11